Hong Thieu

52 year

Health Technology

Consumer Services

Finance

Profile

Hong Thieu worked as an Investment Director at Estag Capital AG and as a Chief Financial Officer at KeyNeurotek Pharmaceuticals AG from 2006 to 2009.
He obtained an undergraduate degree from the University of Siegen.

Former positions of Hong Thieu

Companies	Position	End
Estag Capital AG Estag Capital AG Investment ManagersFinance estag Capital AG is an independent Berlin-based venture capital firm which was founded in 1998 to invest in very early-stage companies.	Chief Investment Officer	31/12/2010
KeyNeurotek Pharmaceuticals AG KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany.	Director of Finance/CFO	-

See the detail of Hong Thieu's experience

Training of Hong Thieu

University of Siegen

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies